brain bank

JACKSONVILLE, Fla. — Mayo Clinic’s Florida campus was awarded a $5.3 million grant from the National Institutes of Health (NIH) to identify vascular risk factors in aging and dementia, and translate that knowledge into studying potential targets for treatment. The grant is one of the first awarded as part of the National Alzheimer’s Project Act, which called for an aggressive and coordinated national Alzheimer’s disease plan. The first goal of the national plan is to prevent and effectively treat Alzheimer’s disease by 2025. Guojun Bu, Ph.D., molecular neuroscientist, and Nilüfer Ertekin-Taner, M.D., Ph.D., neurologist and neurogeneticist, are the principal investigators for the study. Both are based on Mayo Clinic’s Florida campus. Several additional investigators on Mayo’s Florida and Rochester, Minnesota, campuses, as well as Mount Sinai School of Medicine in New York, will be involved. Jounalists: Sound bites with Guojun Bu, Ph.D., and Nilüfer Ertekin-Taner, M.D., Ph.D., are available in the downloads. MEDIA CONTACT: Kevin Punsky, Mayo Clinic Public Affairs, 904-953-0746, punsky.kevin@mayo.edu https://www.youtube.com/watch?v=7jB5i2UZgC0